New trial aims to ease discogenic back pain with targeted nerve ablation
NCT ID NCT07360444
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two procedures—radiofrequency ablation of the rami communicans nerves and annuloplasty—for treating discogenic back pain that hasn't improved with standard care. Ninety adults with chronic low back pain will be randomly assigned to one of the procedures or a combination of both. The goal is to see which approach is safer and more effective at reducing pain and disability over six months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
radiofrequency ablation
What this could lead to
If successful, this could provide a minimally invasive option to reduce chronic discogenic back pain and improve daily function.
What could go wrong
This is a small, early-stage trial (90 people) comparing two procedures, so results may not apply broadly. Risks include pain, infection, or nerve damage from the procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DISCOGENIC BACK PAIN PATIENTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••